» Articles » PMID: 30683100

A Framework for the Ethical Assessment of Chimeric Animal Research Involving Human Neural Tissue

Overview
Journal BMC Med Ethics
Publisher Biomed Central
Specialty Medical Ethics
Date 2019 Jan 27
PMID 30683100
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Animal models of human diseases are often used in biomedical research in place of human subjects. However, results obtained by animal models may fail to hold true for humans. One way of addressing this problem is to make animal models more similar to humans by placing human tissue into animal models, rendering them chimeric. Since technical and ethical limitations make neurological disorders difficult to study in humans, chimeric models with human neural tissue could help advance our understanding of neuropathophysiology.

Main Body: In this article, we examine whether the introduction of human neural tissue and any consequent cognitive change is relevant to the way we ought to treat chimeras. We argue that changes in cognitive abilities are morally relevant to the extent that they increase the capacities that affect the moral status of any entity, including awareness, autonomy, and sociability. We posit that no being, regardless of species, should be treated in a way that is incommensurate with its moral status. Finally, we propose a framework that can be used to guide ethical assessment of research involving chimeras with advanced cognitive capacities.

Conclusion: We advance this framework as a useful tool for bringing relevant considerations to the forefront for those considering the ethical merit of proposed chimeric research. In doing so, we examine concepts relevant to the question of how any entity may be treated, including moral status, dignity, and capacities.

Citing Articles

Knowledge graphs of ethical concerns of cerebral organoids.

Ding L, Xiao Z, Gong X, Peng Y Cell Prolif. 2022; 55(8):e13239.

PMID: 35582763 PMC: 9357362. DOI: 10.1111/cpr.13239.


The ethics of regenerative medicine.

Hermeren G Biol Futur. 2021; 72(2):113-118.

PMID: 34554481 DOI: 10.1007/s42977-021-00075-3.


Perspectives of pluripotent stem cells in livestock.

Kumar D, Talluri T, Selokar N, Hyder I, Kues W World J Stem Cells. 2021; 13(1):1-29.

PMID: 33584977 PMC: 7859985. DOI: 10.4252/wjsc.v13.i1.1.


The new Japanese regulation on human/non-human chimeras: should we worry?.

Raposo V JBRA Assist Reprod. 2020; 25(1):155-161.

PMID: 33118717 PMC: 7863089. DOI: 10.5935/1518-0557.20200045.


The American Public Is Ready to Accept Human-Animal Chimera Research.

Crane A, Shen F, Brown J, Cormack W, Ruiz-Estevez M, Voth J Stem Cell Reports. 2020; 15(4):804-810.

PMID: 33007202 PMC: 7562947. DOI: 10.1016/j.stemcr.2020.08.018.


References
1.
Karpowicz P, Cohen C, van der Kooy D . Developing human-nonhuman chimeras in human stem cell research: ethical issues and boundaries. Kennedy Inst Ethics J. 2005; 15(2):107-34. DOI: 10.1353/ken.2005.0015. View

2.
Streiffer R . At the edge of humanity: human stem cells, chimeras, and moral status. Kennedy Inst Ethics J. 2006; 15(4):347-70. DOI: 10.1353/ken.2005.0030. View

3.
Eberl J, Ballard R . Metaphysical and ethical perspectives on creating animal-human chimeras. J Med Philos. 2009; 34(5):470-86. DOI: 10.1093/jmp/jhp035. View

4.
McCune J, Namikawa R, KANESHIMA H, Shultz L, Lieberman M, Weissman I . The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988; 241(4873):1632-9. DOI: 10.1126/science.241.4873.1632. View

5.
Bok H . What's wrong with confusion?. Am J Bioeth. 2003; 3(3):25-6. DOI: 10.1162/15265160360706471. View